Product Pathways - Tyrosine Kinase / Adaptors
c-Oncogene Antibody Sampler Kit #9328
|9328S||1 Kit (9 x 40 µl)||---||In Stock||---|
Already purchased this product? Write a Review.
|Kit Includes||Quantity||Applications||Reactivity||Homology†||MW (kDa)||Isotype|
|c-Abl Antibody #2862||40 µl||W, IP||H, M, R||135 (c-Abl); 210 (Bcr-Abl)||Rabbit|
|c-Fos (9F6) Rabbit mAb #2250||40 µl||W, IF-IC, F, ChIP||H, M, R||Hm, B, Pg||62||Rabbit IgG|
|c-Jun (60A8) Rabbit mAb #9165||40 µl||W, IP, IHC-P, IHC-F, IF-IC, ChIP||H, M, R, Mk||43, 48||Rabbit IgG|
|c-Kit (D13A2) XP® Rabbit mAb #3074||40 µl||W, IP, IF-IC||H, M||120 and 145||Rabbit|
|c-Myc (D84C12) XP® Rabbit mAb #5605||40 µl||W, IP, IF-IC, F||H, M, R||Mk, Dg, Pg||57-65||Rabbit IgG|
|c-Raf Antibody #9422||40 µl||W||H, M, R, Mk||65 to 75||Rabbit|
|Ras (27H5) Rabbit mAb #3339||40 µl||W||H, M, R, Mk, Dm, Sc||21||Rabbit IgG|
|c-Rel Antibody #4727||40 µl||W, IP, IHC-P, IF-IC, F||H, Mk||78||Rabbit|
|Src (36D10) Rabbit mAb #2109||40 µl||W, IP, IHC-P, IHC-F, IF-F, IF-IC, F||H, M, R, Hm, Mk, B, Pg||C||60||Rabbit IgG|
|Anti-rabbit IgG, HRP-linked Antibody #7074||100 µl||Goat|
†Species predicted to react based on 100% sequence homology.
Applications Key: W=Western Blotting, IP=Immunoprecipitation, IF-IC=Immunofluorescence (Immunocytochemistry), F=Flow Cytometry, ChIP=Chromatin IP, IHC-P=Immunohistochemistry (Paraffin), IHC-F=Immunohistochemistry (Frozen), IF-F=Immunofluorescence (Frozen)
Reactivity Key: H=Human, M=Mouse, R=Rat, Mk=Monkey, Dm=D. melanogaster, Sc=S. cerevisiae, Hm=Hamster, B=Bovine, Pg=Pig
Western blot analysis of extracts from various cell lines using c-Myc (D84C12) XP® Rabbit mAb #5605.
Western blot analysis of extracts from various cell lines using Src (36D10) Rabbit mAb #2109.
Western blot analysis of extracts from HeLa and H-4-II-E cells, serum-starved overnight and TPA-stimulated for 4 hours, using c-Fos (9F6) Rabbit mAb #2250.
Western blot analysis of extracts from LNCap, TT and K-562 cells using c-Abl Antibody #2862.
Western blot analysis of extracts from H526 cells using c-Kit (D132A) XP® Rabbit mAb #3074.
Western blot analysis of extracts from 293T, C2C12 and C6 cells using Ras (27H5) Rabbit mAb #3339.
Western blot analysis of extracts from K-562, Raji and 293 cells using c-Rel Antibody #4727.
Western blot analysis of extracts from NIH/3T3 and SK-N-MC cells, untreated or UV-treated, using c-Jun (60A8) Rabbit mAb #9165.
Western blot analysis of extracts from HeLa, C2C12 and PC-12 cells, untreated or TPA-treated (200 nM for 30 minutes), using c-Raf Antibody #9422.
The c-Oncogene Antibody Sampler Kit provides an economical means of evaluating total levels of various oncogenic proteins. The kit contains enough primary and secondary antibodies to perform four Western blot experiments.
Specificity / Sensitivity
Unless otherwise indicated, each antibody in the c-Oncogene Antibody Sampler Kit detects endogenous levels of total target protein and does not cross-react with related proteins. c-Jun (60A8) Rabbit mAb detects endogenous levels of total c-Jun protein, regardless of phosphorylation state. Ras (27H5) Rabbit mAb detects endogenous levels of total K-Ras, H-Ras and N-Ras proteins. Src (36D10) Rabbit mAb detects endogenous levels of Src proteins and may cross-react with other Src family members. The c-Myc (D84C12) Rabbit mAb detects endogenous levels of total c-Myc protein.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with synthetic peptides corresponding to residues near the carboxy terminus of human c-Rel, a region surrounding Pro302 of human c-Raf, and corresponding to the sequence close to the carboxy-terminus of human c-Abl. Antibodies are purified by protein A and peptide affinity chromatography. Monoclonal antibody is produced by immunizing animals with synthetic peptides corresponding to residues near the carboxy terminus of human Src, residues near the amino terminus of human K-Ras, from the amino-terminal sequence of human c-Jun, from the sequence of human c-Fos, residues near the amino terminus of c-Myc and corresponding to the residues surrounding Tyr703 of human c-Kit.
The regulation of cell growth, differentiation and programmed death is coordinated by several sets of proteins that comprise essential signal transduction pathways. Many of these key regulatory proteins are encoded by proto-oncogenes, which can be activated (altered) to change the typical cell program to one of abnormal cell growth and unregulated development. Proteins encoded by proto-oncogenes include growth factors and other ligands, receptor proteins, tyrosine kinases, various regulatory proteins (i.e. GTPases) and transcription factors. Together these proteins comprise the basic elements of cell signaling pathways; altered expression or mutation of one or more of these components can lead to oncogenic growth (reviewed in 1).
Non-receptor (i.e. cytoplasmic, nuclear) tyrosine kinases such as c-Abl and Src play key roles in the regulation of cell proliferation, differentiation, apoptosis, cell adhesion and stress responses (2,3). Alteration of the corresponding c-Abl and Src proto-oncogenes is associated with oncogenesis; Abl1-BCR gene translocations result in chronic myelogenous leukemia (CML) while constitutively active Src is seen in some patients with colon cancer and altered Src expression is seen in a wide array of cancers (2,4). Regulation of Raf tyrosine kinase by Ras GTPase controls downstream kinases in the MEK/MAPK signaling pathway (5). Activation of the Ras and Raf proto-oncogenes are common in human cancers and both proteins are seen as potential therapeutic targets (6). The receptor tyrosine kinase c-Kit plays a critical role in activation and growth of hematopoietic stem cells (7); mutations that inhibit c-Kit kinase activity are associated with a variety of developmental disorders while mutations producing constitutively active c-Kit can result in mastocytosis and gastrointestinal stromal tumors (8). The alteration of key transcription factors such as c-Fos, c-Jun, c-Myc and c-Rel that are normally responsible for regulating cell and tissue growth, differentiation and the inflammation/immune response, can also result in unregulated, oncogenic cell growth (9-12).
- Croce, C.M. (2008) N Engl J Med 358, 502-11.
- Wang, J.Y. (2000) Oncogene 19, 5643-50.
- Thomas, S.M. and Brugge, J.S. (1997) Annu Rev Cell Dev Biol 13, 513-609.
- Dehm, S.M. and Bonham, K. (2004) Biochem Cell Biol 82, 263-74.
- Avruch, J. et al. (1994) Trends Biochem Sci 19, 279-83.
- Stites, E.C. et al. (2007) Science 318, 463-7.
- Gommerman, J.L. et al. (1997) J Biol Chem 272, 30519-25.
- Nocka, K. et al. (1990) EMBO J 9, 1805-13.
- Milde-Langosch, K. (2005) Eur J Cancer 41, 2449-61.
- Shaulian, E. and Karin, M. (2002) Nat Cell Biol 4, E131-6.
- Yokota, J. et al. (1986) Science 231, 261-5.
- Rayet, B. and Gélinas, C. (1999) Oncogene 18, 6938-47.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7071 Phototope®-HRP Western Blot Detection System, Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
- 9997 Tris Buffered Saline with Tween® 20 (TBST-10X)
- 9998 BSA
- 9999 Nonfat Dry Milk
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
Select rabbit monoclonal antibodies are developed, validated, and produced at CST using in part technology under license (granting certain rights including those under U.S. Patents No. 5,675,063 and in some instances 7,429,487) from Epitomics, Inc.